305 related articles for article (PubMed ID: 26227834)
1. Macular ischemia and outcome of vitrectomy for diabetic macular edema.
Kim J; Kang SW; Shin DH; Kim SJ; Cho GE
Jpn J Ophthalmol; 2015 Sep; 59(5):295-304. PubMed ID: 26227834
[TBL] [Abstract][Full Text] [Related]
2. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
[TBL] [Abstract][Full Text] [Related]
3. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.
Rosenblatt BJ; Shah GK; Sharma S; Bakal J
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):20-5. PubMed ID: 15290152
[TBL] [Abstract][Full Text] [Related]
4. Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema.
Kim JH; Kang SW; Ha HS; Kim JR
Korean J Ophthalmol; 2013 Jun; 27(3):186-93. PubMed ID: 23730111
[TBL] [Abstract][Full Text] [Related]
5. VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.
Bonnin S; Sandali O; Bonnel S; Monin C; El Sanharawi M
Retina; 2015 May; 35(5):921-8. PubMed ID: 25545486
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Kang SW; Park SC; Cho HY; Kang JH
Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
[TBL] [Abstract][Full Text] [Related]
7. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.
Chung EJ; Roh MI; Kwon OW; Koh HJ
Retina; 2008; 28(7):957-63. PubMed ID: 18698297
[TBL] [Abstract][Full Text] [Related]
8. Pars plana vitrectomy and removal of the internal limiting membrane in diabetic macular edema unresponsive to grid laser photocoagulation.
Yanyali A; Horozoglu F; Celik E; Ercalik Y; Nohutcu AF
Eur J Ophthalmol; 2006; 16(4):573-81. PubMed ID: 16952097
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
[TBL] [Abstract][Full Text] [Related]
11. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
Yanyali A; Nohutcu AF; Horozoglu F; Celik E
Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
[TBL] [Abstract][Full Text] [Related]
12. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography.
AttaAllah HR; Mohamed AAM; Ali MA
Int Ophthalmol; 2019 Aug; 39(8):1845-1859. PubMed ID: 30194547
[TBL] [Abstract][Full Text] [Related]
13. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling.
Yamada Y; Suzuma K; Kumagami T; Fujikawa A; Kitaoka T
Ophthalmologica; 2013; 229(3):142-6. PubMed ID: 23257613
[TBL] [Abstract][Full Text] [Related]
14. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
Hartley KL; Smiddy WE; Flynn HW; Murray TG
Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.
Kumar A; Sinha S; Azad R; Sharma YR; Vohra R
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):360-8. PubMed ID: 17093998
[TBL] [Abstract][Full Text] [Related]
17. Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema.
Dillinger P; Mester U
Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):630-7. PubMed ID: 15221304
[TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.
Recchia FM; Ruby AJ; Carvalho Recchia CA
Am J Ophthalmol; 2005 Mar; 139(3):447-54. PubMed ID: 15767052
[TBL] [Abstract][Full Text] [Related]
19. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
